FDA OK for Ranbaxy's quinapril plus HCTZ tablets
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has received approval from the US FDA to manufacture and market quinapril hydrochloride plus hydrochlorothiazide tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg, generic versions of Pfizer's ACE-inhibitor Accuretic tablets.